CS DIAGNOSTICS CORP.

CS Diagnostics Corp.

Medical Devices Healthcare Neuss, Germany CSDX (OQB)

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany.

Stock Performance (90 Days)

Data through Dec 24, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Medical Devices Companies

View All →

Frequently Asked Questions

Has CS DIAGNOSTICS CORP. had layoffs?
No layoff events have been recorded for CS DIAGNOSTICS CORP. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is CS DIAGNOSTICS CORP. in?
CS DIAGNOSTICS CORP. operates in the Medical Devices industry, within the Healthcare sector.
Is CS DIAGNOSTICS CORP. a publicly traded company?
Yes, CS DIAGNOSTICS CORP. is publicly traded under the ticker symbol CSDX on the OQB. The company has a market capitalization of approximately $0.07 billion.
Where is CS DIAGNOSTICS CORP. headquartered?
CS DIAGNOSTICS CORP. is headquartered in Neuss, Germany.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.